ALOPECIA AREATA (& OPHIASIS)
Clinical trials for ALOPECIA AREATA (& OPHIASIS) explained in plain language.
Never miss a new study
Get alerted when new ALOPECIA AREATA (& OPHIASIS) trials appear
Sign up with your email to follow new studies for ALOPECIA AREATA (& OPHIASIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study to settle debate: which drug works best for Kids' hair loss?
Disease control Recruiting nowThis study compares two common drugs, cyclosporine and methotrexate, to treat moderate-to-severe alopecia areata in children aged 2-17. The goal is to see which medicine helps regrow hair better over 9 months. Participants and their parents choose which treatment to try, and doct…
Matched conditions: ALOPECIA AREATA (& OPHIASIS)
Phase: PHASE4 • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Blood test may reveal hidden clues to hair loss severity
Knowledge-focused Recruiting nowThis study investigates whether two substances in the blood—GPX4 and MDA—are linked to the severity of alopecia areata, a condition that causes patchy hair loss. Researchers will compare levels of these markers in 104 people with alopecia areata and 52 healthy volunteers. The goa…
Matched conditions: ALOPECIA AREATA (& OPHIASIS)
Sponsor: Istanbul Training and Research Hospital • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC